Press Release

Jan. 07 2002— Norwell, MA. - Diagenix Corporation today announced that Forum Financial Group is officially in production and taking calls right on schedule. The three-year contract enables Forum Financial Group to offer advanced IVR technology to its customers without the traditional costs of ownership.

The Uni/Mutual IVR application was configured to provide 7x24 access to Mutual Fund values, Portfolio Information, Last Five Transactions, Fund Performance Information and most commonly used forms. Special IVR application features are also available that include listening to a weekly market report message - provided by one of Forum Financial Group's investment committee members.

About Forum Financial Group

Forum Financial Group, established in 1986, is a leading service provider to the global mutual fund, offshore fund and hedge fund industries. From its operation centers in the United States, Poland, Bermuda and Malta, Forum provides comprehensive fund administration, accounting, transfer agency, shareholder services, and custody to pooled investment vehicles. Forum's domestic operations are headquartered in Portland, Maine, where Forum services more than $100 billion in client assets.
About Diagenix
Diagenix is an innovative voice application company that provides enterprise-class voice, speech, and IVR solutions that enable organizations to provide anytime, anywhere access to information and resources over the telephone and via the internet. Diagenix makes voice- and web-based services strategic tools for improving customer service, reducing costs, and improving workforce productivity. Our customers include FORTUNE 500 organizations throughout the U.S. and Canada as well as government agencies. Diagenix products and services are sold and distributed through a direct sales organization and through select business partners.

For more information about Diagenix and its products and services, please visit our website at or call us at 781-871-6624.
Contact Information
Press Contacts:
Anton Arapoff
Diagenix Corp.